국가: 이스라엘
언어: 히브리어
출처: Ministry of Health
Inspire MD LTD
בית חולים
InspireMD LTD
רופא
MGuard Prime Coronary Stent System is indicated for improving luminal diameter in vessels with reference diameter from 2.5 to 4.0 mm having lesion length <38 mm and providing embolic protection in the following cases: • Symptomatic coronary artery disease due to discrete de novo or restenotic lesion in native coronary artery. • Symptomatic coronary artery disease due to culprit lesion in saphenous vein graft • Treatment of coronary lesion in patients undergoing primary or rescue PCI for acute ST-segment elevation myocardial infarction(STEMI) • Treatment of coronary lesion having atherothrombotic appearance in patients with non ST-elevation acute coronary syndromes (unstable angina and non ST-segment elevation myocardial infarction).
MGuard Prime Coronary Stent System is indicated for improving luminal diameter in vessels with reference diameter from 2.5 to 4.0 mm having lesion length <38 mm and providing embolic protection in the following cases: • Symptomatic coronary artery disease due to discrete de novo or restenotic lesion in native coronary artery. • Symptomatic coronary artery disease due to culprit lesion in saphenous vein graft • Treatment of coronary lesion in patients undergoing primary or rescue PCI for acute ST-segment ele